Progyny (PGNY) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- $0.34
- EPS estimate
- $0.33
- EPS surprise
- +1.58%
- Revenue surprise
- +0.54%
- Revenue
- $350.5M
- Revenue estimate
- $348.6M
- Reported
- Aug 6, 2026
Progyny reported Q2 2026 results on August 6, 2026. Earnings per share were $0.34, ahead of the $0.33 estimate by 1.58%. Revenue was $350.5 million, just above the $348.6 million consensus. Compared with Q2 2025, EPS rose about 79% from $0.19 and revenue rose about 5% from $332.9 million.
Annual revenue rose from $786.9 million in 2022 to $1.09 billion in 2023, $1.17 billion in 2024 and $1.29 billion in 2025. Q2 2026 set the highs here for both revenue and EPS. Annual EPS moved less evenly: $0.30 in 2022, $0.62 in 2023, $0.57 in 2024 and $0.65 in 2025. The first half of 2026 adds up to $0.63 per share, nearly matching all of 2025 and up from $0.36 a year earlier. Progyny was profitable in every quarter shown. It beat the EPS estimate 17 times in 20 quarters; the misses were Q3 2024, Q1 2025 and Q4 2025.
Q3 results came out between November 3 and November 12 in each of the past five years. That points to early or mid-November 2026 for the next report. It will show whether the faster EPS growth of the first half carries into the third quarter.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 6, 2026 | $0.33 | $0.34 | +1.58% | $350.5M | SEC |
| Q1 2026 | May 7, 2026 | $0.26 | $0.29 | +13.28% | $328.5M | SEC |
| Q4 2025 | Feb 26, 2026 | $0.15 | $0.14 | −4.76% | $318.4M | SEC |
| Q3 2025 | Nov 6, 2025 | $0.13 | $0.15 | +17.92% | $313.3M | SEC |
| Q2 2025 | Aug 7, 2025 | $0.16 | $0.19 | +20.10% | $332.9M | SEC |
| Q1 2025 | May 8, 2025 | $0.19 | $0.17 | −10.71% | $324.0M | SEC |
| Q4 2024 | Feb 27, 2025 | $0.10 | $0.12 | +25.00% | $298.4M | SEC |
| Q3 2024 | Nov 12, 2024 | $0.14 | $0.11 | −23.08% | $286.6M | SEC |
| Q2 2024 | Aug 6, 2024 | $0.17 | $0.17 | +0.35% | $304.1M | SEC |
| Q1 2024 | May 9, 2024 | $0.13 | $0.17 | +28.50% | $278.1M | SEC |
| Q4 2023 | Feb 27, 2024 | $0.11 | $0.13 | +20.93% | $269.9M | SEC |
| Q3 2023 | Nov 7, 2023 | $0.11 | $0.16 | +39.62% | $280.9M | SEC |
| Q2 2023 | Aug 3, 2023 | $0.10 | $0.15 | +45.91% | $279.4M | SEC |
| Q1 2023 | May 8, 2023 | $0.07 | $0.18 | +142.26% | $258.4M | SEC |
| Q4 2022 | Feb 27, 2023 | $0.02 | $0.03 | +50.00% | $214.3M | SEC |
| Q3 2022 | Nov 3, 2022 | $0.03 | $0.13 | +333.33% | $205.4M | SEC |
| Q2 2022 | Aug 4, 2022 | $0.01 | $0.09 | +620.00% | $195.0M | SEC |
| Q1 2022 | May 5, 2022 | −$0.02 | $0.05 | +399.40% | $172.2M | SEC |
| Q4 2021 | Feb 28, 2022 | $0.04 | $0.15 | +316.67% | $127.6M | SEC |
| Q3 2021 | Nov 4, 2021 | $0.06 | $0.17 | +173.31% | $122.3M | SEC |
Quarterly revenue
Frequently asked questions
When did Progyny (PGNY) last report earnings?
Progyny last reported on Aug 6, 2026, covering fiscal Q2 2026.
Did PGNY beat earnings estimates?
Yes. Progyny reported EPS of $0.34 for Q2 2026 against a $0.33 estimate — a 1.58% beat.
How much revenue did PGNY report last quarter?
Progyny reported $350.5M in revenue for Q2 2026, against a consensus estimate of $348.6M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.